taxnews.ey.comPrint

02 September 2026

Trump administration announces Most Favored Nation deals with nine additional pharmaceutical manufacturers

On August 31, the White House announced new "Most Favored Nation" (MFN) agreements with nine mid-sized pharmaceutical manufacturers that aim to more closely align US drug prices with those offered in other developed nations. The agreements also include commitments from several of the companies to donate active pharmaceutical ingredients (APIs) to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). The White House said the agreements are intended to address what it views as an imbalance in pharmaceutical pricing between the United States and other countries.

Additional information is available in the WCEY Health Alert, attached below.

* * * * * * * * * *
Attachment

New Most Favored Nation deals

* * * * * * * * * *
Contact Information

For questions on MFN deals, please contact:

For questions on tariffs, please contact:

Document ID: 2026-1882

 

The information contained herein is general in nature and is not intended, and should not be construed, as legal, accounting or tax advice or opinion provided by Ernst & Young LLP to the reader. The reader also is cautioned that this material may not be applicable to, or suitable for, the reader's specific circumstances or needs, and may require consideration of non-tax and other tax factors if any action is to be contemplated. The reader should contact his or her Ernst & Young LLP or other tax professional prior to taking any action based upon this information. Ernst & Young LLP assumes no obligation to inform the reader of any changes in tax laws or other factors that could affect the information contained herein.

 

Copyright © 1996 – 2026, Ernst & Young LLP

 

All rights reserved. No part of this document may be reproduced, retransmitted or otherwise redistributed in any form or by any means, electronic or mechanical, including by photocopying, facsimile transmission, recording, rekeying, or using any information storage and retrieval system, without written permission from Ernst & Young LLP.

 

EY US Tax News Update Master Agreement | EY Privacy Statement